De Burlo Group’s Bristol-Myers Squibb BMY Stock Holding History

De Burlo Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,520	Closed	-$611K	–	86
2023 Q4	$611K	Hold	10,520	–	–	0.11%	67
2023 Q3	$611K	Sell	10,520 -8,430	-44%	-$517K	0.11%	67
2023 Q2	$1.21M	Sell	18,950 -300	-2%	-$20.1K	0.2%	58
2023 Q1	$1.33M	Sell	19,250 -550	-3%	-$38.8K	0.26%	58
2022 Q4	$1.42M	Buy	19,800 +100	+0.5%	+$7.54K	0.32%	47
2022 Q3	$1.4M	Sell	19,700 -2,427	-11%	-$176K	0.33%	48
2022 Q2	$1.7M	Buy	22,127 +1,477	+7%	+$112K	0.49%	23
2022 Q1	$1.51M	Sell	20,650 -3,100	-13%	-$208K	0.28%	50
2021 Q4	$1.48M	Sell	23,750 -3,600	-13%	-$211K	0.22%	64
2021 Q3	$1.62M	Buy	27,350 +100	+0.4%	+$6.59K	0.26%	60
2021 Q2	$1.82M	Hold	27,250	–	–	0.29%	54
2021 Q1	$1.72M	Sell	27,250 -500	-2%	-$31.1K	0.31%	55
2020 Q4	$1.72M	Hold	27,750	–	–	0.28%	51
2020 Q3	$1.67M	Buy	+27,750	New	+$1.67M	0.3%	52
2016 Q4	–	Sell	-36,387	Closed	-$1.96M	–	98
2016 Q3	$1.96M	Sell	36,387 -115,300	-76%	-$7.41M	0.54%	65
2016 Q2	$11.2M	Buy	151,687 +65,000	+75%	+$4.59M	2.7%	8
2016 Q1	$5.54M	Sell	86,687 -27,500	-24%	-$1.73M	1.6%	21
2015 Q4	$7.85M	Buy	114,187 +69,800	+157%	+$4.61M	1.85%	21
2015 Q3	$2.63M	Buy	44,387 +9,000	+25%	+$571K	0.62%	54
2015 Q2	$2.35M	Buy	+35,387	New	+$2.33M	0.49%	64

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

De Burlo Group's BMY Position: Q1 2024 in Review

De Burlo Group sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 10,520 shares — an estimated $611K sold.

De Burlo Group first reported a position in BMY in Q2 2015 and held it in 20 quarters. The position peaked at $11.2M in Q2 2016. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

De Burlo Group reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
De Burlo Group sold 10,520 Bristol-Myers Squibb shares in Q1 2024, an estimated $611K.
De Burlo Group first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 20 quarters.
De Burlo Group's Bristol-Myers Squibb position peaked at $11.2M in Q2 2016.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on De Burlo Group's 13F filing for Q1 2024, filed 13 May 2024.